|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
28.300 +1.300 (+4.815%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,349,489 | -6.985% | 1,450,828 | 1,599,079 | 1,390,945 | 1,135,591 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 20,665 | -26.538% | 28,130 | 30,652 | 6,055 | 2,428 |
| Interests in Asso. & JCEs | 159,038 | -15.574% | 188,375 | 197,944 | 9,685 | 10,087 |
| Other Non-current Assets | 69,587 | 17.894% | 59,025 | 52,861 | 21,860 | 30,774 |
| 1,598,779 | -7.390% | 1,726,358 | 1,880,536 | 1,428,545 | 1,178,880 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 3,890 | -47.546% | 7,416 | 18,604 | 15,140 | 7,980 | |
| Trade Receivables | 229,608 | 61.260% | 142,384 | 107,682 | 103,089 | 67,226 | |
| Cash & Bank Balances | 384,458 | -3.791% | 399,607 | 610,882 | 466,445 | 750,044 | |
| Other Current Assets | 198,579 | 14.360% | 173,643 | 182,128 | 289,564 | 322,388 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 816,535 | 12.929% | 723,050 | 919,296 | 874,238 | 1,147,638 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 115,479 | -34.100% | 175,234 | 146,190 | 102,441 | 87,599 | ||
| S-T Debt & Leases | 225,995 | 11.219% | 203,199 | 171,603 | 26,897 | 14,106 | ||
| Other Current Liabilities | 193,439 | -2.884% | 199,183 | 288,253 | 317,221 | 226,760 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 534,913 | -7.393% | 577,616 | 606,046 | 446,559 | 328,465 | |||
| Net Current Assets | 281,622 | 93.642% | 145,434 | 313,250 | 427,679 | 819,173 | ||
| Total Assets Less Current Liabilities | 1,880,401 | 0.460% | 1,871,792 | 2,193,786 | 1,856,224 | 1,998,053 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 344,282 | 0.989% | 340,910 | 243,677 | 62,902 | 66,812 | |||
| Other Non-current Liabilities | 697,518 | -5.798% | 740,446 | 799,293 | 541,351 | 473,000 | |||
| 1,041,800 | -3.658% | 1,081,356 | 1,042,970 | 604,253 | 539,812 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 399,398 | 0.000% | 399,398 | 399,398 | 374,930 | 360,000 | ||||
| Reserves | 434,658 | 12.464% | 386,488 | 746,867 | 872,278 | 1,093,411 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 834,056 | 6.129% | 785,886 | 1,146,265 | 1,247,208 | 1,453,411 | ||||
| Non-controlling Interests | 4,545 | -0.110% | 4,550 | 4,551 | 4,763 | 4,830 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 838,601 | 6.093% | 790,436 | 1,150,816 | 1,251,971 | 1,458,241 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | 0 | -- | 12,458 | 8,838 | 52,575 | 262,905 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 47,999 |
| %Change | -- |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.233 |